In the new study, Alter and colleagues tested the Moderna mRNA vaccine against the older form of vaccine in a group of 18 ...

Research from the drug company Moderna suggests its new mpox vaccine, based on mRNA technology, might be more effective than ...

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...

The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of ...

Europe-listed shares fell 7% Thursday, the day after a study showed Moderna's (MRNA) mpox vaccine appeared to be more ...

In late August the WHO declared a surging outbreak of mpox in Africa a public health emergency of international concern, the ...

Amid mounting concerns about the spread of mpox, an experimental vaccine from Moderna may be poised to offer additional ...

A new type of mpox, clade Ib, has been spreading rapidly within the Democratic Republic of Congo and leaking outside the ...

Moderna ( NASDAQ: MRNA) has secured regulatory approval in the U.K. and Taiwan for an updated formulation of its COVID-19 ...

Investigational mpox mRNA vaccine, developed by Moderna, reduces disease severity in primates compared to available vaccines.

Shares of Moderna Inc. MRNA slid 0.62% to $72.49 Wednesday, on what proved to be an all-around mixed trading session for the ...

To counter new forms of the virus, FDA approved updated vaccines from both Pfizer and Moderna last week. These new vaccines ...